<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Shuang Li - Research Publications</title>
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        body {
            font-family: 'Lato', sans-serif;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            line-height: 1.6;
            color: #333;
            margin: 0;
            padding: 0;
        }
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        .navbar {
            background-color: #ffffff;
            border-bottom: 1px solid #e7e7e7;
            padding: 10px 0;
            position: sticky;
            top: 0;
            z-index: 1000;
        }
        .navbar-nav {
            list-style-type: none;
            padding: 0;
            margin: 0;
            display: flex;
            justify-content: center;
        }
        .navbar-nav li {
            margin: 0 15px;
        }
        .navbar-nav a {
            color: #666666;
            text-decoration: none;
            font-weight: bold;
            font-size: 18px;
        }
        h1, h2, h3, h4 {
            color: #1a5f7a;
        }
        main {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        .paper {
            background-color: #ffffff;
            border-radius: 8px;
            box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
            margin-bottom: 30px;
            padding: 20px;
        }
        .paper-title {
            font-size: 1.5em;
            margin-bottom: 10px;
        }
        .paper-links {
            margin-bottom: 20px;
        }
        .button {
            display: inline-block;
            padding: 8px 16px;
            margin-right: 10px;
            background-color: #1a5f7a;
            color: #ffffff;
            text-decoration: none;
            border-radius: 4px;
            font-size: 14px;
        }
        .paper-details {
            display: flex;
            flex-wrap: wrap;
            gap: 20px;
        }
        .paper-content {
            flex: 1;
            min-width: 300px;
        }
        .paper-content h3 {
            color: #1a5f7a;
            margin-top: 20px;
            margin-bottom: 10px;
        }
        .paper-content p {
            line-height: 1.8;
            text-align: justify;
        }
        .paper-content ul {
            line-height: 1.8;
        }
        footer {
            text-align: center;
            padding: 20px;
            background-color: #f5f7fa;
            margin-top: 40px;
        }
    </style>
</head>
<body>
    <nav class="navbar">
        <div class="container">
            <ul class="navbar-nav">
                <li><a href="/">Home</a></li>
                <li><a href="/publication/">Research</a></li>
            </ul>
        </div>
    </nav>

    <main>
        <h1>Research Publications</h1>

        <div class="paper">
            <h2 class="paper-title">Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial Cells</h2>
            <p><strong>Li S</strong>, van Dijk CGM, Meeldijk J, et al.</p>
            <p><em>Front Oncol.</em> 2021 Jun 9;11:681967.</p>

            <div class="paper-links">
                <a href="https://doi.org/10.3389/fonc.2021.681967" class="button">ðŸ“„ Read Paper</a>
                <a href="https://www.frontiersin.org/journals/oncology" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Abstract:</h3>
                <p>This study investigates how extracellular Granzyme K modulates angiogenesis through the regulation of soluble VEGFR1 release from endothelial cells. The findings provide insights into the role of granzymes in cancer biology and potential therapeutic targets for anti-angiogenic therapies.</p>
                
                <h3>Key Contribution:</h3>
                <p>First-author publication demonstrating novel mechanisms of granzyme-mediated angiogenesis regulation in breast cancer research, utilizing CRISPR knockout models and flow cytometry.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Pediatric Medulloblastoma Express Immune Checkpoint B7-H3</h2>
            <p><strong>Li S</strong>, Poolen G, van Vliet L, et al.</p>
            <p><em>Clin Transl Oncol.</em> 2022 Jun;24(6):1204-1208.</p>

            <div class="paper-links">
                <a href="https://doi.org/10.1007/s12094-021-02762-y" class="button">ðŸ“„ Read Paper</a>
                <a href="https://link.springer.com/journal/12094" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Abstract:</h3>
                <p>This research validates the expression of immune checkpoint B7-H3 in pediatric medulloblastoma, identifying it as a potential therapeutic target for immunotherapy in pediatric brain tumors. The study employs comprehensive immunohistochemical analysis and flow cytometry to characterize B7-H3 expression patterns.</p>
                
                <h3>Key Contribution:</h3>
                <p>First-author publication establishing B7-H3 as a relevant immune checkpoint in pediatric medulloblastoma, with implications for developing targeted immunotherapies for pediatric cancer patients.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives</h2>
            <p>Voskamp MJâ€ , <strong>Li Sâ€ </strong>, van Daalen KR, et al.</p>
            <p><em>Cancers.</em> 2021 Oct 27;13(21):5387.</p>
            <p style="font-style: italic; color: #666;">(â€ Co-first author)</p>

            <div class="paper-links">
                <a href="https://doi.org/10.3390/cancers13215387" class="button">ðŸ“„ Read Paper</a>
                <a href="https://www.mdpi.com/journal/cancers" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Abstract:</h3>
                <p>This comprehensive review examines the current state of immunotherapy research in medulloblastoma, discussing key challenges and future perspectives for developing effective immunotherapeutic strategies for this pediatric brain tumor. The review covers various immunotherapy approaches including checkpoint inhibitors, CAR-T cell therapy, and vaccine-based strategies.</p>
                
                <h3>Key Contribution:</h3>
                <p>Co-first author of this comprehensive review article that synthesizes current knowledge on immunotherapy approaches for medulloblastoma and provides insights into future research directions and clinical applications.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Disease-Associated Plasmacytoid Dendritic Cells</h2>
            <p><strong>Li S</strong>, Wu J, Zhu S, Liu YJ, Chen J.</p>
            <p><em>Front Immunol.</em> 2017 Oct 16;8:1268.</p>

            <div class="paper-links">
                <a href="https://doi.org/10.3389/fimmu.2017.01268" class="button">ðŸ“„ Read Paper</a>
                <a href="https://www.frontiersin.org/journals/immunology" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Abstract:</h3>
                <p>This study investigates disease-associated plasmacytoid dendritic cells (pDCs) and their roles in various disease contexts. The research provides comprehensive insights into pDC biology, their activation mechanisms through toll-like receptors, and their involvement in breast cancer, autoimmune diseases, and viral infections.</p>
                
                <h3>Key Contribution:</h3>
                <p>First-author publication from Master's research demonstrating expertise in dendritic cell biology, flow cytometry, and in vitro/in vivo experimental models, with focus on TLR-activated pDCs in cancer immunology.</p>
            </div>
        </div>
    </main>

    <footer>
        <p>Â© 2025 Shuang Li. All rights reserved.</p>
    </footer>
</body>
</html>
